IMC Chicago’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.75M Sell
16,700
-1,200
-7% -$299K ﹤0.01% 2039
2025
Q4
$4.31M Buy
17,900
+5,500
+44% +$1.41M ﹤0.01% 1846
2025
Q3
$3.39M Sell
12,400
-9,800
-44% -$2.68M ﹤0.01% 1868
2025
Q2
$5.73M Buy
22,200
+5,600
+34% +$1.34M ﹤0.01% 1309
2025
Q1
$3.72M Buy
16,600
+4,500
+37% +$1.05M ﹤0.01% 1395
2024
Q4
$2.77M Sell
12,100
-18,900
-61% -$4.55M ﹤0.01% 1626
2024
Q3
$7.57M Hold
31,000
﹤0.01% 943
2024
Q2
$5.93M Buy
31,000
+13,000
+72% +$2.64M ﹤0.01% 994
2024
Q1
$3.56M Buy
+18,000
New +$3.3M ﹤0.01% 1099

Other funds holding RMD

IMC Chicago's RMD Position: Q3 2024 in Review

IMC Chicago sold out of ResMed (RMD) in Q3 2024, closing a stake of 16,977 shares — an estimated $3.79M sold.

IMC Chicago first reported a position in RMD in Q2 2024 and held it in 1 quarter. The position peaked at $3.25M in Q2 2024. 801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

  • IMC Chicago reported no remaining ResMed position as of Q3 2024 after selling out during the quarter.
  • IMC Chicago sold 16,977 ResMed shares in Q3 2024, an estimated $3.79M.
  • IMC Chicago first reported a position in ResMed in Q2 2024 and held it in 1 quarter.
  • IMC Chicago's ResMed position peaked at $3.25M in Q2 2024.
  • 801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on IMC Chicago's 13F filing for Q3 2024, filed 25 Oct 2024.